Add to MyYahoo RSS

Cholesterol News

News on Cholesterol continually updated from thousands of sources around the net.

2 hrs ago | PhysOrg Weblog

High-dose rosuvastatin shrinks coronary plaque in heart attack patients

One year of treatment with the highest dose of the cholesterol-lowering drug rosuvastatin can shrink plaque inside the arteries of patients who have had a certain type of heart attack known as ST-segment elevation myocardial infarction , according to a new study presented today at ESC Congress 2014.


Related Topix: Medicine, Health, Heart Attack, Switzerland, World News, Cardiology, Europe

Mon Sep 01, 2014

Personal Injury Law News

South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as...

The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug.


Related Topix: Lipitor, Atorvastatin (generic), Medicine, Health

PhysOrg Weblog

Investigational agent outshines ezetimibe for lowering cholesterol

The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and elevated risk of cardiovascular disease , according to the ODYSSEY COMBO II trial, presented as a Hot Line today at ESC Congress 2014.


Related Topix: Health, Zetia, Ezetimibe (generic)

Sun Aug 31, 2014

News Max

New Cholesterol Drug Cuts Heart Risk in Half

An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday.


Related Topix: Medicine, Health, Biotech, Regeneron Pharmaceuticals, Healthcare Industry, Cardiology, University of Iowa


Sanofi-Regeneron's Amgen Drug Rival Cuts Cholesterol

Sanofi and Regeneron Pharmaceuticals Inc. 's cholesterol drug cut levels of the heart disease-causing fat in four studies, and there are early indications it may prevent death and heart attack.


Related Topix: Medicine, Health, Biotech, Amgen, Healthcare Industry, Regeneron Pharmaceuticals, Genetics, Healthcare Law, Law

Fri Aug 29, 2014

Medical News Today

New national guidelines can improve the way statin drugs are...

The research, recently published in the Journal of the American College of Cardiology , also showed the new guidelines produce only a modest increase in the number of patients being given the drugs.


Related Topix: Medicine, Health, Lipitor, Atorvastatin (generic), Zocor, Simvastatin (generic), Pravachol, Pravastatin (generic), Galloway, NJ

Thu Aug 28, 2014


Socioeconomic status and gender are associated with differences in cholesterol levels

A long-term lifestyle study reports differences between the sexes when it comes to fat profiles associated with socioeconomic status.


Related Topix: Medicine, Health


CDC: There's more trans fats lurking in U.S. foods than you think

"The sense is that trans fat is mostly gone from foods, and what we see is there's still a lot being used in packaged foods," said Christine Curtis , assistant commissioner in the New York City health department and an author of the study.


Related Topix: Centers for Disease Control and Prevention, Medicine, Health


Trans fat still lurking in U.S. food supply

Nearly one in 10 processed food products sold in the United States has trans fat in it - but you'd never know it by glancing at the nutritional label on the back of the package, according to a new study released Thursday by the Centers for Disease Control and Prevention.


Related Topix: Health


UPDATE 1-Amgen seeks U.S. approval of new cholesterol-fighting drug

Amgen Inc said on Thursday it applied to U.S. health regulators to sell its cholesterol fighter, evolocumab, becoming the first company to seek approval of a medicine from a closely watched new class of potent heart drugs.


Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Health, Lipitor, Atorvastatin (generic)


Amgen Submits BLA For Cholesterol Drug Evolocumab

Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration for evolocumab seeking approval for the treatment of ... (more)


Related Topix: Medicine, Health, Biotech, Amgen, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Genetics

Applied Clinical Trials

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial ...

Patients were randomized to one of eight treatment groups to compare subcutaneous evolocumab with subcutaneous placebo when added to different daily doses of atorvastatin.


Related Topix: Medicine, Health, Mathematics, Science, Lipitor, Atorvastatin (generic)

Mon Aug 25, 2014

New statin guidelines are an improvement, Yale study shows

New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.


Related Topix: Yale University, Medicine, Health, Lipitor, Atorvastatin (generic), Zocor, Simvastatin (generic), Pravachol, Pravastatin (generic), Galloway, NJ

Sun Aug 24, 2014

Cupuacu fruit is a natural pharmacy and fountain of youth rolled into one

Part of the same Theobroma botanical genus as cacao, cupuacu is a watermelon-sized Amazonian superfruit that is renowned for its capacity to dissolve body fat, minimize the effects of aging and boost cognitive function.


Related Topix: Life, Fruits, Medicine, Health

Seward City News

Rules for Vicodin pain medication changing October 6th, 2014

Hydrocodone is a popular, widely prescribed pain medication. In 2012, 135 million prescriptions were written for this medication across the united states.


Related Topix: Medicine, Vicodin, Acetaminophen/Hydrocodone (generic), Health, Pain, Zocor, Simvastatin (generic), Drug Enforcement Administration, Drugs

Wed Aug 20, 2014


Reconstituted High-Density Lipoprotein Therapies: A Cause for Optimism [Editorials]

From the Division of Cardiovascular Medicine and Division of Translational Medicine and Human Genetics , Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.


Related Topix: Genetics, Medicine, University of Pennsylvania, Philadelphia, PA, Health, Heart Disease

Medical News Today

Heart and stroke risks in diabetic women reduced 30 percent by cholesterol drug

The cholesterol-lowering drug fenofibrate cuts cardiovascular disease risks by 30 per cent in women with type-2 diabetes , a new University of Sydney study reveals.


Related Topix: Medicine, Health, Tricor, Fenofibrate (generic), Diabetes, Heart Disease, Triglycerides, Heart Attack

Mon Aug 18, 2014

Lipids in Health and Disease

Cardiovascular and cancer events in hyper-high-density lipoprotein...

The prognosis for hyper-high-density lipoprotein cholesterolemic patients has not been fully elucidated.


Related Topix: Life, Food, Dieting, Medicine, Health, Pravachol, Pravastatin (generic), Heart Disease

Medical Daily

Stroke And Heart Attack Risk Falls By 30% Among Select Women With New Cholesterol Drug

Women who are at risk for heart attack or stroke may find hope thanks to a new drug.


Related Topix: Medicine, Heart Attack, Heart Disease, Tricor, Fenofibrate (generic)

Statin drugs may help fight Ebola

Statin medications used to treat people with heart disease and diabetes may help fight Ebola , according to physicians writing an editorial in a recent edition of the New York Times .


Related Topix: Medicine, Diabetes, Health, University of Virginia, Infectious Diseases, Lipitor, Atorvastatin (generic)